Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mouse Nerve Growth Factor for sudden hearing loss
ChiCTR2200064397Phase 4Not yet recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mouse nerve growth factor in acute sensorineural hearing loss (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Hearing tests. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
mouse nerve growth factor
03
Conditions
acute sensorineural hearing loss
Beyond the preview
Go deeper on ChiCTR2200064397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064397.